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Abstract
Background: Precise determination of conformational epitopes of neutralizing antibodies represents a key step in the rational design 
of novel vaccines. A powerful experimental method to gain insights on the physical chemical nature of conformational epitopes is the 
selection of linear peptides that bind with high affinities to a monoclonal antibody of interest by phage display technology. However, 
the structural characterization of conformational epitopes from these mimotopes is not straightforward, and in the past the interpretation 
of peptide sequences from phage display experiments focused on linear sequence analysis to find a consensus sequence or common 
sequence motifs.
Results: We present a fully automated search method, EpiSearch that predicts the possible location of conformational epitopes on the 
surface of an antigen. The algorithm uses peptide sequences from phage display experiments as input, and ranks all surface exposed 
patches according to the frequency distribution of similar residues in the peptides and in the patch. We have tested the performance of 
the EpiSearch algorithm for six experimental data sets of phage display experiments, the human epidermal growth factor receptor-2 
(HER-2/neu), the antibody mAb Bo2C11 targeting the C2 domain of FVIII, antibodies mAb 17b and mAb b12 of the HIV envelope 
protein gp120, mAb 13b5 targeting HIV-1 capsid protein and 80R of the SARS coronavirus spike protein. In all these examples the 
conformational epitopes as determined by the X-ray crystal structures of the antibody-antigen complexes, were found within the highest 
scoring patches of EpiSearch, covering in most cases more than 50% residues of experimental observed conformational epitopes. Input 
options of the program include mapping of a single peptide or a set of peptides on the antigen structure, and the results of the calculation 
can be visualized on our interactive web server.
Availability: Users can access the EpiSearch from our web server http://curie.utmb.edu/episearch.html
Contact: webraun@utmb.edu
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Introduction
The  identification  of  conformational  epitopes  in 
antibody-antigen  interaction  is  a  crucial  step  for 
the  rational  design  of  novel  drugs  and  vaccines. 
The most direct experimental method to accurately 
define an epitope is to determine the 3D structure 
of  the  antibody-antigen  complex  by  X-ray 
crystallography1–5 however these methods are time-
consuming and need purified protein complexes. An 
alternative approach makes use of screening biological 
peptide libraries with antibodies to identify peptides 
that mimic conformational epitopes.6–8 A library of 
peptides  is  generated  by  filamentous  phages  that 
display a random set of peptides on their surfaces. 
The  antigen  binding  site  on  the  antibody,  used  in 
the  screening,  will  select  those  peptides  from  the 
random phase libraries that have a subset of similar 
residues in common with the conformational epitope 
of the antigen. In iterative procedures of biopanning 
the libraries with the antibody of interest, residues 
important  for  binding  can  then  be  enriched  in  the 
phage sequences. Phage display methods have been 
shown to experimentally identify residues critical for 
antigen-antibody interactions.6–14 It has been shown 
that the peptides obtained from random phage libraries 
can mimic conformational epitopes, thus they are also 
referred as mimotopes.9,13–17 The peptide sequences of 
mimotopes are found quite often be different from 
those of the natural antigen, thus the assignment of 
conformational epitopes from the peptide sequences 
can  not  be  done  by  sequence  alignment  of  the 
selected peptides with the sequence of the antigen. 
Conformational epitopes are formed in most cases by 
a small group of amino acid residues scattered along 
the protein sequence yet form contiguous clusters of 
residues on the protein surface.9,17,18 Methods using 
only the linear sequence of the antigen are thus not 
applicable in most cases.
In  the  current  work,  we  developed  a  fully 
automated  computational  method,  EpiSearch 
(http://curie.utmb.edu/episearch.html)  to  map  a 
conformational epitope on the antigen protein surface 
from  phage  display  sequences  without  manual 
intervention. EpiSearch is based on a patch analysis 
that identifies spatial contiguous clusters of residues 
on the surface of the antigen with similar physical-
chemical  properties  as  found  in  the  phage  display 
sequences. Similarity of residues is measured by a 
physical-chemical property distance that was derived 
from five descriptors of amino acid residues.19–24 The 
performance  of  the  EpiSearch  algorithm  has  been 
tested for six experimental data sets of phage display 
experiments  and  compared  to  the  conformational 
epitopes as found by the X-ray crystal structures of 
the corresponding antibody-antigen complexes. The 
highest-scoring patch of EpiSearch was found in all 
the  test  cases  overlapping  with  the  experimentally 
observed conformational epitopes, and the predicted 
conformational epitopes cover in most cases more 
than 50% residues of the conformational epitopes. 
In the online version of  the EpiSearch method, users can 
map a single consensus sequence or up to thirty peptide 
sequences at a time. The output results from EpiSearch 
are displayed in a table and automatically mapped on 
the 3D structure using Jmol molecule viewer.25
Methods
The conformational epitopes on the protein surface 
are predicted by an automated sequence analysis of 
all phage display sequences and a comparison to the 
distributions  of  amino  acids  on  three-dimensional 
patches  on  the  protein  surface.  The  amino  acid 
compositions  of  the  linear  and  3D  profiles  are 
compared and quantified in a score function for each 
patch  on  the  protein  surface.  The  highest  scoring 
patches  are  listed  in  the  output  files  and  are  also 
displayed on the surface of the protein. An overview 
of the implemented procedure in EpiSearch is given 
in Figure 1.
Amino acid composition in the phage 
display sequences
The input of EpiSearch uses the set of M sequences 
from phage display experiments (labeled j = 1, ..., M) 
that mimic the surface residues of an antibody binding 
sites and the 3D structure of the antigen. The frequency 
distributions of residues for these peptide sequences 
are stored in a matrix mat1 (M, 20) with M rows and 
20 columns.
Amino acid composition  
of the surface patches
The  protein  surface  of  the  antigen  is  decomposed 
in overlapping surface patches around each solvent 
accessible amino acid residue. Therefore, in a protein 
with N solvent accessible residues, we have N number Automated detection of conformational epitopes using phage display peptide sequences
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of surface patches, labeled k = 1, ..., N. The solvent 
accessible surface area of each residue is calculated 
by GetArea26 with a probe radius of 1.4Å. A residue 
is  considered  to  be  solvent  exposed  if  its  solvent 
accessible surface area is greater than 10Å2 otherwise 
the residues are considered as buried in the protein.22,24 
The surface exposed residues are represented by their 
Cβ atom (Cα atom in case of Gly residue). Using 
the Cβ position of each residue (Cα atom in case of 
Gly residue), a surface patch of radius R is drawn 
around each surface exposed residues. The frequency 
distribution  of  amino  acid  residues  in  each  patch 
is calculated and saved into a second matrix mat2 
(N, 20). A patch size of radius 12Å was used for all 
calculations with EpiSearch. Empirically, a patch size 
of radius 12Å was chosen to cover the surface area of 
all the residues present in the input peptide sequences 
(in most of the test cases the input peptide sequence is 
12 residues long). An increase of the patch size may 
increase the sensitivity of the method but at the same 
time it will also decrease the precision of the method. 
On other hand a decrease in patch size may predict 
a smaller number of  residues and therefore decrease 
the sensitivity of the method.
Criterion for matching residues
In order to map a peptide on the protein surface, we 
calculate the property distance PD (A, B) of residues 
A in the peptide sequences and residues B in each 
patch as:
  PD A B E A E B i
i
i i ( , ) ( ( ) ( )) = − ∑λ
2
  (1)
where the Ei (i = 1,5) are five quantitative descriptors 
representing  physicochemical  properties  of 
amino acids and λi are the eigen values of the ith 
component of E.19,21 If two amino acid residues are 
identical, their PD value is zero, and similar amino 
acid  residues  have  small  PD  values.  We  used  a 
cutoff value of PD = 8.0 as the criterion to have 
matching residues between phage display sequences 
Figure 1. Flow chart of the episearch method used to map peptide sequences obtained from phage display experiment onto 3D protein structure.negi and Braun
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and surface patches. We found empirically that this 
PD value represents a good threshold for residues 
with similar properties. The number of matching 
residues in each peptide j and patch k are then stored 
in a new matrix Xj
k.
score function of surface patches
Finally, for a given peptide j, the total number of 
predicted  residues  in  each  patch  k  is  normalized 
using
  SIM
X X
X X
k n j
k j
k
j
j j
=
−
−
=
min
max min
, , , for 1 2 …   (2)
where, Xminj and Xmaxj are the minimum and maximum 
number of matching residues present in all patches 
for a given peptide sequence j. This normalization 
transforms the number of matching residues for each 
peptide j to a uniform range; i.e. a SIMj
k value of 
1 represent a patch k with the maximum number of 
matching residues for a given peptide j, and a SIMj
k 
value  of  0  represent  a  patch  k  with  the  minimum 
number  of  matches.  The  process  is  repeated  over 
all input peptide sequences j. We then select only 
patches  as  potential  candidates  for  conformational 
epitopes if they have SIMj
k values greater than 0.5 for 
all peptides j; i.e. patches have a reasonable good 
match with all peptides. The final score, Scorek, of 
each selected patch k is then calculated as the average 
over all M peptides,
  Score
M
SIM
k
j
k
j
M
=
= ∑
1
1
  (3)
The  highest  scoring  patch  is  selected  as  the 
predicted  patch,  and  those  individual  residues 
within  the  predicted  patch  that  match  at  least  one 
of the peptide sequences are predicted as part of the 
conformational epitope.
Definition of the observed conformational 
epitope derived from the X-ray structure 
of the antibody-antigen complex
A  residue  is  considered  as  part  of  the  observed 
epitope  in  the  X-ray  crystal-structure  of  the 
antibody-antigen complex, if the residue changes its 
solvent accessible surface area by more than 10Å2 in 
complex formation.
Results
Mapping of trastuzumab peptides
As a first test for the performance of our procedure we 
selected the trastuzumab epitope. Trastuzumab, also 
known under the trade name Herceptin, is a humanized 
monoclonal antibody that inhibits growth of Her-2/
neu expressing tumor cells, and has been approved 
as  immunotherapy  for  breast  cancer  patients.27–30 
The  group  of  E.  Jensen-Jarolim  has  isolated  five 
peptides  each  12  residue  long  from  phage  display 
experiments to characterize the epitope of the antibody 
trastuzumab on the human epidermal growth factor 
receptor-2, Her-2/neu.28,29 The conformational epitope 
of trastuzumab on Her-2/neu has also been determined 
by  a  co-crystal  structure  of  a  trastuzumab  Fab 
fragment with the extra cellular domain of the HER2 
receptor, PDB id: 1N8Z.30 Main residues representing 
the conformational trastuzumab epitope are located in 
the C terminal of domain-IV with the three segments 
of  amino  acids  557–561,  569–573  and  591–603 
respectively. Multiple sequence alignment shows no 
consensus region between the sequences of the phage 
display peptides and the HER-2/neu sequence.28
High scoring patches on Her-2/neu were predicted 
by EpiSearch in two locations ranging from residues 
200 to 300 and 550 to 600 (Fig. 2A). The patch with 
the highest score (0.910) was found with the center 
at residue C565, and the second highest score was 
found centered at residue C214 (Score: 0.882). The 
individual score profiles for all 5 peptides are shown 
in  a  close-up  views  in  Figure  2B  and  Figure  2C. 
Patches at the third and fourth rank were found at 
K569 with a score 0.774 and at Y568 (Score: 0.766) 
overlapping  with  the  patch  at  C565.  Other  high 
scoring patches at residues 272 and 283 are near the 
patch centered at C214 on the surface of Her-2/neu.
The patch at residue C565 with the highest score 
coincides to a large extent with the experimentally 
determined  epitope  of  the  antibody—Her-2/neu 
complex  which  is  shown  in  red  in  Figure  3A. 
A  detailed  view  of  the  predicted  patch  site  at 
C565  shows  residues  on  the  surface  of  Her-2/neu 
that  match  residues  in  the  peptide  sequences,  i.e. 
these  are  the  predicted  residues  within  the  patch 
(in green) and other residues of the patch are shown Automated detection of conformational epitopes using phage display peptide sequences
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in orange (Fig. 3B). Most of these predicted residues 
are correct, as shown in red in Figure 3C, and only 
a  few  residues  of  the  experimentally  determined 
epitope are not predicted (shown in blue). The second 
highest scoring patch at residue C214 was located 
on the other face of the HER-2, and is not part of 
the interface of the antibody—Her-2/neu complex. 
However both the patches share a large fraction of 
amino acids present in the input peptide sequences. 
This patch is also predicted as one of the top rank 
cluster in Mapitope analysis.17
Mapping of mAb Bo2C11 epitopes
Next, we compared the performance of the EpiSearch 
method  to  map  the  epitopes  recognized  by  mAb 
Bo2C11 on the C2 domain of coagulation factor VIII 
(FVIII). Bo2C11 is a human anti FVIII monoclonal 
antibody  that  binds  to  C2  domain  of  FVIII,  an 
essential cofactor in the intrinsic pathway of blood 
coagulation. Deficiency of FVIII results in bleeding 
disorder commonly known as hemophilia A.9,31–33 We 
used a list of 27 peptides each 12 residue long selected 
against  mAb  Bo2C11  targeting  the  C2  domain  of 
FVIII.31 Using the X-ray crystal structure of the C2 
domain of FVIII34 (PDB id:1IQD), EpiSearch method 
predicted  a  potential  epitope  on  the  C2  domain  of 
FVIII that correspond to a patch centered at the residue 
R2220 with the highest score (0.937). The predicted 
residues  form  a  large  part  of  the  conformational 
epitope as determined by the X-ray crystal structure 
of the Bo2C11 mAb-C2 domain (Fig. 4A). The residue 
R2220  is  completely  buried  at  the  Fab  interface 
and forms a salt bridge with the residue D102 on 
the Fab Bo2C11 while residues H2315 and Q2316 
play  an  important  role  in  polar  interactions  at  the 
antibody  interface.34  Other  three  patches  predicted 
by EpiSearch method are centered on the residues 
P2205  (Score:  0.881),  E2228  (Score:  0.804)  and 
Y2195  (Score:  0.769)  respectively.  The  residues 
predicted  in  these  patches  are  also  present  in  the 
Bo2C11 binding site. The predicted residues from the 
highest scoring patch are shown in Figure 4B, and 
to a large extent correctly predicted to be part of the 
interface are shown in Figure 4C.
Mapping of mAb b12 and mAb 17b 
epitopes
In  order  to  map  the  conformational  epitopes  of 
mAb  b1213  onto  the  crystal  structure  of  gp120 
(PDB  id:  2NY7)  we  selected  nineteen  12-mer 
cysteine  looped  peptides.  Using  default  value  of 
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Figure 2. A) Average score profile of five trastuzumab peptides CQMWAPQWGPDC, CKLYWADGELTC, CKLYWADGEFTC, CVDYHYEGTITC, and 
CVDYHYEGAITC in each patch centered on the surface exposed residues of HER2 protein surface is shown. B–c) shows the score profile for the five 
peptides at the two high scoring patches centered at residues 214 and 565, respectively.negi and Braun
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Figure  3.  Comparison  of  the  genuine  epitope  site  on  her2  surface 
obtained from X-ray crystallography with the epitope site predicted by 
the episearch method. A) The amino acids at the genuine epitope site 
on her-2 surface (red). B) The amino acids predicted by the episearch 
method present in the highest scoring patch centered on C565 and also 
present in the input peptide sequences (green), while the residues not 
present in the input peptide sequences are shown in orange. c) Amino 
acids correctly predicted and present in the genuine epitope binding site 
on her2 surface (red), while the residues present in the epitope site and 
not predicted are shown in blue.
parameters,  EpiSearch  method  predicted  a  high 
scoring patch centered on residue T283 (Score: 0.943). 
A  comparison  between  the  residues  located  in  the 
predicted patch with those located at the interface of 
gp120-mAb b12 complex revealed that the EpiSearch 
method correctly predicted the residues N280, A281, 
K282, R469, T455, G472, G473 and M475 as part 
of the conformational epitope. We also observed that 
the  residues  D279,  N280,  A281,  K282  and  T283 
predicted in the high scoring patch coincide with the 
CD4 binding site in the gp120.13,35 When the analysis 
was  repeated  after  removing  the  terminal  cysteine 
residues from the peptide sequences, a high scoring 
patch centered at T283 (Score: 0.911) was predicted. 
This indicates that the method is able to predict the 
location of the conformational epitope correctly with 
or without the terminal cysteine residue.
We also mapped the conformational epitopes of  mAb 
17b onto the crystal structure of gp12036 using eleven 
12-mer cysteine looped peptides of the mAb 17b.18 The 
EpiSearch analysis predicted two high scoring patches 
centered on residues L116 (Score: 0.780) and L122 
(Score: 0.683). The patches partially overlap with each 
other and share more than 70% of the residues present 
in the input peptide sequences. We observed that the 
accuracy of the method was lowered by removing the 
terminal cysteine residues from the peptide sequences. 
This  may  be  attributed  to  the  presence  of  cysteine 
residue  in  the  epitope  binding  site  which  has  been 
shown critical for stabilizing the gp120 core.35–37
Mapping of mAb 13b5 epitopes
A list of fourteen 12-mer cysteine-loop peptides of 
mAb 13b518 that bind HIV-1 capsid protein (p24)38,39 
(PDB id: 1E6J) were selected. Using default value 
of  the  parameters,  EpiSearch  method  predicted 
two top scoring patches centered on residues M214 
(Score: 0.813) and R100 (Score: 0.805). The patch 
M214 was located in the C-terminal while the patch 
centered at R100 was located in the N-terminal region 
of p24. Earlier, the crystal structure of  HIV-1 p24-mAb 
13b5 shows that the antibody recognizes a region in the 
C-terminal domain of p24 between the residues L205 
to E213.39 However, the dimeric structure of  the p24, as 
observed in the type II crystal, shows a dimer interface 
between N-terminal domain of one molecule with the 
C-terminal  domain  of  two  fold  related  molecule.38 
This observation brings the locations of  both predicted Automated detection of conformational epitopes using phage display peptide sequences
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patches in a close proximity in the dimer structure. 
Both high scoring patches centered at M214 and R100 
were also obtained when the analysis was repeated 
after removal of the terminal cysteine residues from 
the  input  sequences.  The  location  of  the  predicted 
patch M214 on HIV-1 p24 surface corresponds to the 
experimentally observed conformational epitope.
Mapping neutralizing epitope 80r 
on SARS CoV spike protein
In this example, we selected a list of eighteen peptide 
sequences each fifteen residues long derived from the 
libraries of random linear peptides40 and mapped them 
onto the surface of SARS Coronavirus Spike protein 
receptor binding domain 2 (PDB id: 2AJF).41 Using 
the default value of input parameters, we obtained 
two high scoring patches centered at residues F460 
(Score: 0.844) and L443 (Score: 0.804). The amino 
acids  predicted  by  the  EpiSearch  method  were 
observed at the interface site of the spike protein and 
its receptor ACE2, and may represent the possible 
binding  site  for  anti-SARS  monoclonal  antibody, 
80R.  When  the  peptide  sequences  were  tested 
independently, we found that with the exception of the 
peptide no 12 and 16, ten peptides mapped correctly 
in the interface region while five mapped in a patch 
centered  at  residue  L355,  a  site  also  predicted  by 
Tarnovitski et al40 on SARS Coronoavirus. Very low 
sequence identity among the input peptide sequences 
may  be  responsible  for  the  prediction  of  multiple 
binding  sites.  However,  all  the  peptide  sequences 
satisfying the criteria defined by equation (3) were 
found in a patch centered at residue F460.
performance of the Method
The  EpiSearch  method  was  successfully  validated 
using six independent test cases where input peptide 
sequences from phage display experiments as well as 
the X-ray co-crystal structures of antigen-antibody were 
available. Table 1 gives an overview of the accuracy of 
EpiSearch method and shows that the method correctly 
predicted  the  location  of  conformational  epitopes. 
Despite the low sequence similarity among the input 
peptide sequences, the residues in the highest scoring 
patch  shared  approximately  70%  sequence  identity 
with the residues in the input peptide sequences. In 
our analysis, we observed that, though all the residues 
Figure  4.  A) Amino  acids  in  C2  domain  of  FVIII  (red)  complex  with 
Bo2C11 Fab. B) The residues predicted by the episearch method in 
the highest scoring patch and present in the input peptide sequences 
are shown in green while the residues not present in the input peptide 
sequences are shown in orange. c) Amino acids correctly predicted and 
present in the Bo2C11 binding site (red), while the residues present in 
the Bo2C11 binding site and not predicted are shown in blue.negi and Braun
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in the input peptide sequences were not present in the 
epitope binding sites, a highest scoring patch correctly 
predicted the location of the conformational epitopes 
as  found  in  the  crystal  structure.  Except  in  case  of 
mAb 17b peptides, the extent of coverage to locate the 
conformational epitope site in all the test cases was 
found to be more than 50% (Table 1). In case of mAb 
17b the second high scoring patch performed better than 
the top scoring patch. The second high scoring patch 
partially  overlapped  with  the  top  scoring  patch  and 
contained seven of the eleven residues present in the 
mAb 17b interface. In case of Trastuzumab, mAb 17b, 
mAb b12 and mAb 13b5 peptides, we also determined 
the influence of terminal cysteine (Cys) residues on 
the quality of the results. Experimentally, the terminal 
cysteine  residues  were  introduced  to  constrain  the 
peptides to a cyclic structure and might influence the 
selection process. We observed that in most of the cases 
the result was not sensitive to the presence of the Cys 
as terminal residues. However, in the case of mAb 17b 
bound gp120 the constrained loop peptides gave a better 
result than the analysis performed without the terminal 
Cys residues, which is evident from the presence of a 
Cys residue in the epitope binding site of gp120.35,36
The  performance  of  the  EpiSearch  method  was 
compared  with  the  online  version  of  the  PepSurf 
method  (http://pepitope.tau.ac.il/),42  see  Table  2. 
We observed that PepSurf method groups the input 
peptide sequences based on their sequence identity 
and maps the high scoring group on to antigen surface. 
However in case of the EpiSearch method all input 
peptide sequences satisfying equation 2 were mapped 
on the antigen surface.
Discussion and conclusions
It is generally believed that not all amino acids in a 
protein interface contribute to the affinity of binding 
of a protein complex in a uniform way, and major 
contributions  to  the  binding  energies  of  a  protein 
complex  are  composed  from  a  small  fraction  of 
amino acids present in the protein surface, known as 
hot spots.22,43–47 However, flexible peptides that bind 
to the antigen binding site of an antibody can use 
different binding modes not necessarily identical to a 
relatively rigid protein surface. The EpiSearch method 
assumes that all peptides that are selected during the 
bio-panning process use a subset of the actual antigen-
antibody interactions, and that the ensemble of all 
sequences  sample  most  of  favourable  interactions 
in  the  protein-antibody  interface.  Therefore  only 
surface  patches  that  have  a  relative  high  number 
of  matching  residues  for  all  peptide  sequences 
are  selected  in  our  prediction  process.  We  also 
assume that some of the physical pair interactions 
Table 1. Performance of the EpiSearch method for six independent test cases. Results are shown for the highest scoring 
patch, for the gp120-mAb 17b complex we also include the data for the second scoring patch. In all six cases the highest 
scoring patches overlap with the experimentally known epitopes as shown in the number of correctly predicted residues 
(column 6). This number is then compared to the number of all residues in the epitope sites (column 4), given as coverage, 
TP/(TP + Fn), in column 7, and also compared to the number of all predicted residues in that patch, given as overlap ratio, 
TP/(TP + FP), in column 8. TP = correctly predicted amino acids, Fn = amino acids not predicted and FP = amino acids 
predicted incorrectly on the protein surface.
name  
of antibody
number 
of input 
peptides
Highest 
patch 
score
number  
of interface 
residues*
number  
of residues 
in a patch
number  
of correctly 
predicted 
residues
extent  
of coverage
Overlap 
ratio
cpU Time 
(second)
Trastuzumab 5 0.91 14 27 9 0.64 0.33 62
mAb Bo2C11 27 0.93 14 20 7 0.50 0.35 43
mAb b12 19 0.94 18 26 8 0.44 0.31 46
mAb 17b†1 11 0.78 11 27 2 0.18 0.07 29
mAb 17b†2 11 0.68 11 19 7 0.64 0.37 29
mAb 13b5 14 0.81 12 21 12 1.00 0.57 21
80r 18 0.84 16 22 6 0.38 0.27 24
†Both first1 and second2 high scoring patches are shown.
*Interface residues are calculated if the change is AsA more than 10Å2 in complex formation.Automated detection of conformational epitopes using phage display peptide sequences
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in the protein-antibody interface can be replaced by 
residue pairs with similar physicochemical properties, 
e.g. hydrophobic interactions, polar-polar or charge-
charge interactions. Thus our method does not only 
match residues of identical types, but also residues 
with similar physicochemical properties, i.e. with low 
PD values.
The number of antigen-antibody complexes that are 
experimentally determined by X-ray crystallography 
is continuously increasing in the protein data bank,48 
however  mapping  the  conformational  epitopes  by 
phage display experiments is an alternative method to 
the 3D-structure determination in case a high affinity 
complex  can  not  be  isolated.  The  phage  display 
technique  first  introduced  by  G.  Smith49  has  been 
successfully used to screen a large peptide libraries 
that binds to a specific antibody. Simple comparison 
of the linear sequences of the selected peptides to the 
sequence of the antigen is in most cases not possible, 
as  the  peptides  selected  from  the  phage  display 
experiment  represent  discontinuous  fragments 
of amino acids that may not have a high sequence 
homology to the antigen. The test cases we present 
here show that our EpiSearch method is a reliable 
technique to help in the interpretation of the peptide 
sequences.
A  number  of  computational  methods  used  to 
identify the epitopes on the antigen structure have 
been reported earlier.9,13,15–18,33,37,42,50–52 Most of these 
methods  are  either  computationally  expensive 
or  unable  to  process  a  large  number  of  peptide 
sequences  at  a  time  as  discussed  in  detail  by 
Mayrose et al.37 EnShell-Seijffers et al18 described a 
method that can be used to find the most frequent 
tandem pairs of amino acids selected from the phage 
display  peptide  library. The  algorithm  defines  the 
statistically significant pairs of amino acids (AAP) 
by calculating the distance between two Cα atoms 
of adjacent residues. The AAP can be considered if 
the distance between to consecutive Cα is less than a 
given threshold value, D (the distance between alpha 
carbon of any given pair). Each peptide sequence 
obtained from the phage libraries are deconvoluted 
into AAPs and the most significant pairs were mapped 
on the protein surface. A new version of Enshell et al 
algorithm known as Mapitope,17 is available which 
depends on the selection of the distance between Cα 
atoms of any given pair and the statistical threshold 
values.  Other  methods,  Findmap,53  3DEX16  and 
MIMOX33 uses one peptide sequence (or a consensus 
peptide  sequence)  at  a  time  while  PepSurf  37,42 
becomes  highly  CPU  time  intensive  when  longer 
peptides  are  used37  and  the  performance  of  the 
MIMOP9 relies on the multiple sequence alignment 
of peptide sequences. The ability of the EpiSearch 
method to predict genuine epitope binding site on 
the antigen surface was also tested using a single 
peptide sequence as well as a group of three, five 
and if possible nine, fourteen and twenty sequences. 
As shown in Table 1, the EpiSearch method correctly 
mapped  the  location  of  conformation  epitopes. 
However,  subtle  differences  were  observed  when 
Table 2. Performance of the PepSurf method using five independent test cases is shown. In case of trastuzumab epitope a 
third high scoring cluster on her2 surface in contact with the trastuzumab was selected.
name 
of antibody
number 
of input 
peptides
Highest 
patch 
score
number  
of interface 
residues*
number  
of residues 
in a patch
number  
of correctly 
predicted 
residues
extent  
of coverage#
Overlap 
ratio1
cpU Time 
(second)
Trastuzumab† 5 10.567 14 11 4 0.29 0.36 –
mAb Bo2C11 27 771.98 14 22 2 0.14 0.09 –
mAb b12 19 745.45 18 39 3 0.16 0.10 –
mAb 17b 11 306.38 11 29 6 0.55 0.20 –
mAb 13b5 14 635.15 12 26 11 0.92 0.42 –
80r$ – – – – – – – –
†result from correctly predicted cluster (third) is shown.
#Relative to actually observed in epitope TP/(TP + Fn) (extent of coverage), 1Relative to total predicted residues TP/(TP + FP) (overall ratio) as defined in 
table 1.
$No results available from PepSurf web server as PepSurf can not accept peptide sequences longer than 14 amino acids.negi and Braun
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the input peptide sequences shared a low sequence 
identity.16,17,33,42
Major advantages of EpiSearch are its flexibility 
for handling a single peptide sequence or a group of 
peptide sequences and its efficiency to process a large 
number of  peptide sequences in a very short time. Based 
on tested examples shown here the average processing 
time is about one minute which may vary depending 
on the size of the input protein data file used. Also the 
EpiSearch method is flexible enough and allows the 
user to vary the cut off value for solvent accessible 
surface area of amino acids and the patch size. For 
example, in the case of  Trastuzumab peptides, the 
method correctly predicts six residues using a 10Å 
patch size and three residues using a patch size of 8Å 
compared to nine residues using a patch size of 12Å. 
Similarly, in the case of mAb Bo2C11, the method 
correctly predicts five residues using a patch size of 
10Å compared to seven residues using a patch size of 
12Å. A further decrease in patch size predicts only four 
residues. A patch size below 10Å can accommodate 
fewer  residues  present  in  the  12-mer  peptide  and 
therefore  recommends  to  use  peptide  sequences 
up to seven (7-mer) or nine (9-mer) residues long. 
The results obtained from the web server are shown 
interactively in a tabular form as well on the protein 
surface using JMOL molecular viewer.25 In addition, 
using  the  information  about  the  surface  exposed 
residues,  EpiSearch  method  can  be  used  to  design 
peptides  that  might  interfere  with  protein-protein 
interactions. Also, we hope that the results obtained 
from the EpiSearch method in combination with the 
information available from site directed mutagenesis 
will provide a vital resource to understand the nature 
of the antigen-antibody interaction in greater details. 
An automated version of the method is freely available 
online at http://curie.utmb.edu/episearch.html.
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